Naftopidil

CHEMBL142635 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

392.5 g/mol

LogP

4.1

Phase

4

An alpha-1 adrenergic receptor blocker used in Japan and other Asian countries to treat benign prostatic hyperplasia, relieving urinary symptoms by relaxing smooth muscle in the prostate and bladder neck. It may also have benefits for sexual function.

Moleküler Ağırlık

392,5000 g/mol

LogP

4,10

TPSA

45,20 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Benign Prostatic Hyperplasia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1

InChI

InChI=1S/C24H28N2O3/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23/h2-12,20,27H,13-18H2,1H3

Molecular Formula

C24H28N2O3

HBD / HBA

1 / 5

Döndürülebilir Bağlar

7

Ağır Atomlar

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An alpha-1 adrenergic receptor blocker used in Japan and other Asian countries to treat benign prostatic hyperplasia, relieving urinary symptoms by relaxing smooth muscle in the prostate and bladder neck. It may also have benefits for sexual function.

Yes, Naftopidil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL142635. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4418. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Naftopidil PillFYI'da

Yapı

Hızlı Veriler

Formül: C24H28N2O3

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.